Data / Drug companies / Sato Pharmaceutical Co., Ltd.
Sato Pharmaceutical Co., Ltd.: 33 products in the FDA NDC directory, labeler code 49873
Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).
Sato Pharmaceutical Co., Ltd. (labeler code 49873) lists 33 products in the FDA National Drug Code Directory, covering 25 finished drugs by generic name. By type: 33 over the counter drugs. Its main marketing category is over the counter monograph drugs. The newest product started marketing on September 1, 2024.
The request: Watch Sato Pharmaceutical Co., Ltd. (FDA labeler code 49873): each new product listing and each discontinued product. $10 of work on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Labeler code
- 49873
- Products in commercial distribution
- 33
- Packages
- 35
- Finished drugs by generic name
- 25
- Prescription products
- 0
- Over the counter products
- 33
- Flagged as original packager
- 33 of 33 products that carry the flag
- Started marketing in the last 12 months
- 0
- Earliest marketing start
- July 15, 1981
- openFDA record search
- api.fda.gov
Products by marketing category
Share of the company's products in commercial distribution.
| Marketing category | Products | Share |
|---|---|---|
| Over the counter monograph drugs | 33 | 100% |
Products by type
| Type | Products | Share |
|---|---|---|
| Over the counter drugs | 33 | 100% |
Drugs it lists
Finished drugs by generic name, with how many companies list each.
| Drug | Products | Companies listing it |
|---|---|---|
| Tolnaftate | 2 | 99 |
| Camphor, capsaicin, menthol | 2 | 2 |
| Dl-camphor, l-menthol, methyl salicylate | 2 | 2 |
| Methyl salicylate, dl-camphor, l-menthol | 2 | 1 |
| Dimenhydrinate | 1 | 21 |
| Lidocaine, menthol | 1 | 34 |
| Hydrocortisone acetate | 1 | 35 |
| Diphenhydramine hydrochloride, menthol | 1 | 2 |
| Capsaicin | 1 | 66 |
| Diphenhydramine hydrochloride, levomenthol | 1 | 1 |
| Acetaminophen | 1 | 214 |
| Dextromethorphan hydrobromide | 1 | 17 |
| Glycerin | 1 | 56 |
| Camphor, menthol, methyl salicylate | 1 | 36 |
| Meclizine hydrochloride | 1 | 41 |
| Benzalkonium chloride, lidocaine hydrochloride | 1 | 18 |
| Lidocaine hydrochloride | 1 | 134 |
| Aluminum hydroxide, magnesium carbonate, sodium bicarbonate | 1 | 1 |
| Chlorpheniramine maleate, phenylephrine | 1 | 1 |
| Magnesium aluminosilicates, magnesium hydroxide, simethicone | 1 | 1 |
| Naphazoline hydrochloride | 1 | 3 |
| Salicylic acid | 1 | 330 |
| Dextromethorphan hydrobromide, guaifenesin | 1 | 49 |
| Magnesium aluminosilicate, magnesium hydroxide | 1 | 1 |
| Docusate sodium, sennosides | 1 | 18 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Tablet | 8 | 24.2% |
| Patch | 5 | 15.2% |
| Lotion | 3 | 9.1% |
| Ointment | 2 | 6.1% |
| Solution | 2 | 6.1% |
| Cream | 2 | 6.1% |
| Spray | 2 | 6.1% |
| Liquid | 2 | 6.1% |
| Syrup | 2 | 6.1% |
| Gel | 1 | 3% |
| Lozenge | 1 | 3% |
| Capsule | 1 | 3% |
Pharmacologic classes
FDA established pharmacologic classes of its products.
Newest products
By marketing start date.
| Product | Product NDC | Dosage form | Marketing category | Marketing start |
|---|---|---|---|---|
| SATOHAP COOL and HOT | 49873-622 | Patch | Over the counter monograph drugs | September 1, 2024 |
| ZenTrip Motion Sickness | 49873-805 | Tablet | Over the counter monograph drugs | May 1, 2021 |
| Satohap Cool and Hot Pads | 49873-621 | Patch | Over the counter monograph drugs | December 18, 2020 |
| Satohap Cool Type | 49873-620 | Lotion | Over the counter monograph drugs | January 10, 2019 |
| Satohap Lidocaine Hydrochloride 4 Percent Pain Relieving | 49873-618 | Lotion | Over the counter monograph drugs | November 19, 2018 |
| Satohap Lidocaine 4% Menthol 1% Pain Relieving Cream | 49873-619 | Cream | Over the counter monograph drugs | November 14, 2018 |
| Satogesic Hot | 49873-608 | Patch | Over the counter monograph drugs | November 22, 2006 |
| Satohap | 49873-068 | Spray | Over the counter monograph drugs | November 3, 2006 |
| Airmit Ace | 49873-802 | Tablet | Over the counter monograph drugs | March 11, 2005 |
| Stona Cough | 49873-306 | Tablet | Over the counter monograph drugs | November 24, 2004 |
| Stona | 49873-114 | Tablet | Over the counter monograph drugs | September 29, 2004 |
| Stona-S | 49873-113 | Capsule | Over the counter monograph drugs | September 27, 2004 |
| Sankaijo | 49873-404 | Tablet | Over the counter monograph drugs | December 20, 2002 |
| Stonarhini | 49873-109 | Tablet | Over the counter monograph drugs | November 16, 2001 |
| Stona Cough | 49873-302 | Syrup | Over the counter monograph drugs | January 3, 2001 |
| Stona for Children | 49873-108 | Syrup | Over the counter monograph drugs | January 3, 2001 |
| Inon Ace | 49873-403 | Solution | Over the counter monograph drugs | May 20, 2000 |
| Tact Cool Jelly | 49873-704 | Gel | Over the counter monograph drugs | October 2, 1997 |
| Tact | 49873-705 | Cream | Over the counter monograph drugs | September 9, 1997 |
| Hi Vetic | 49873-056 | Ointment | Over the counter monograph drugs | October 25, 1996 |
| Ringl | 49873-082 | Tablet | Over the counter monograph drugs | May 9, 1996 |
| Stona | 49873-301 | Lozenge | Over the counter monograph drugs | November 19, 1995 |
| Inon Ace | 49873-402 | Tablet | Over the counter monograph drugs | November 1, 1995 |
| Poli-A | 49873-703 | Ointment | Over the counter monograph drugs | March 19, 1995 |
| Minica-s | 49873-401 | Enema | Over the counter monograph drugs | May 1, 1994 |
CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.